Analysts/Institutional Investor Meet/Con. Call Updates

Ref: MOL/2026-27/63 November 7, 2026 To, To, National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Bandra-Kurla Complex, Floor- 25, P J Tower, Bandra (East) Dalal Street, Mumbai 400 051 Mumbai 400 001 SYMBOL:- MOL Scrip Code:- 543331 Dear Sir, Sub: Transcript of Earnings Conference call held on November 5, 2026 to discuss Q2 FY27 Financial Results. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith transcript of Earnings Conference Call held on November 5, 2026 to discuss Q2 FY27 Financial Results. The said transcript is also available at www.meghmani.com in the investor section. You are requested to kindly take the same on your record. Thanking you, Yours faithfully, For Meghmani Organics Limited Naresh Prajapati Company Secretary ICSI Mem. No: A44816 Encl: As above “Meghmani Organics Limited Q2 FY27 Earnings Conference Call” November 05, 2026 MANAGEMENT: MR. ANKIT PATEL – CHAIRMAN AND MANAGING DIRECTOR – MEGHMANI ORGANICS LIMITED MR. G.S. CHAHAL – CHIEF FINANCIAL OFFICER – MEGHMANI ORGANICS LIMITED MR. PRATIK SHAH – DEPUTY CHIEF FINANCIAL OFFICER – MEGHMANI ORGANICS LIMITED MR. NISHANT VYAS – INVESTOR RELATIONS – MEGHMANI ORGANICS LIMITED MODERATOR: MS. RUSHALI SADANI – ARIHANT CAPITAL MARKETS LIMITED Meghmani Organics Limited November 05, 2026 Moderator: Ladies and gentlemen, good day and welcome to Meghmani Organics Limited Q2 FY27 Earnings Conference Call hosted by Arihant Capital Markets Limited. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing star then zero on your touch-tone phone. Please note that this conference is being recorded. I now hand the conference over to Ms. Rushali Sadani from Arihant Capital Markets Limited. Thank you, and over to you, ma'am. Rushali Sadani: Thank you. Good morning, everyone. Welcome to you all to Meghmani Organics Limited for Q2 H1 FY27 earnings con-call. On behalf of Arihant Capital Limited, I would like to thank the management of Meghmani Organics Limited for giving us this opportunity to host this call. Today, from the management side, we have Mr. Ankit Patel, Chairman and Managing Director; Mr. G.S. Chahal, Chief Financial Officer; Mr. Pratik Shah, Deputy CFO; and Mr. Nishant Vyas, Investor Relations. Without any further delay, I would like to hand over the call to the management for the opening remarks. Ankit Patel: Thank you Rushali Ji. Good morning, everyone. And thank you for joining us on our Q2 FY27 earnings call. I believe you have had a chance to go through the financial results and investor presentation uploaded on the stock exchanges and the website. Before we move to the quarterly and half-yearly financial performance review. I would like to share that we have received the Honorable NCLT's approval for the amalgamation of our two wholly owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, with Meghmani Organics Limited, creating a single unified legal entity. This approval marks an important milestone in our journey. The scheme will enable us to achieve optimal utilization of existing resources through consolidation of operations and derive operational and financial synergies. Moving to our quarterly performance review. During the quarter, we delivered a healthy revenue growth with revenue increasing 18% year-on-year basis and 26% quarter-on-quarter basis, reflecting a continued positive momentum. However, due to a sharp increase in input and logistics costs and realization remaining broadly flat, our margins during the quarter were impacted. While the near-term cost environment remains challenging, we are taking focused measures to optimize our product mix, enhance operating efficiencies and strengthen profitability. We remain focused on navigating the current environment while sustaining the underlying growth momentum of the business. Page 2 of 11 Meghmani Organics Limited November 05, 2026 On a standalone basis, in Q2 FY27, revenue stood at nearly INR658 crores, up by 18% year- on-year basis. Net profit for the quarter increased by 6% to INR45 crores on a year-on-year basis, while our EBITDA remained flat at INR70.9 crores. Our EBITDA margin for the quarter was impacted by elevated input and logistics costs. If we talk about the revenue mix in Q2 FY27, the Crop Protection segment constitutes about 75% of the total revenue, while the balance 25% was from the Pigment segment. Now let us look at the segment-wise performance. In the Crop Protection segment, production stood at nearly 10,000 metric tons, and the capacity utilization for the segment stood at 72%. Revenue and EBITDA stood at nearly INR496 crores and INR54 crores, respectively. EBITDA margin for the segment was at about 11%. For the Pigment segment production stood at 4,252 metric tons, and capacity utilization for the segment stood at 51%. The segment reported revenue and EBITDA of INR161 crores and INR16 crores, respectively. EBITDA margin for the segment was at about 10%. For the half year ended 30th September 2026, revenue from operations stood at INR1,181 crores, which is up by 3% year-on-year basis. Net profit increased by 23% to approximately INR103 crores, and EBITDA grew by 9% to INR164 crores. Moving to our Crop Nutrition segment. We have commenced the production of our newly introduced Nano fertilizer products like Nano DAP, Nano NPK, and Nano Zinc at our existing manufacturing facility in Sanand. These products complement our existing product portfolio and position us well to participate in the growing adoption of next-generation crop nutrition solutions. We remain optimistic about the long-term growth prospects of this business. In titanium dioxide, operations continue to remain suspended due to commercial unviability arising from the elevated raw material costs and weaker price realization following the withdrawal of antidumping duty. Recently, on 24th October 2026, the Ministry of Finance re-imposed antidumping duty on titanium dioxide imports from China for a period of 5 years. While this is a positive development and should support a gradual improvement in the price realization, the economics of restarting the plant remain challenging. Sulfuric acid, a key raw material, is currently at a significantly elevated level, with prices having increased by nearly 7 to 8x from the normal levels. Considering these factors, restarting operations is not commercially viable. Now, if we look at our financial performance on a consolidated basis in Q2 FY27, revenue stood at nearly INR666 crores, up by 16% on a year-on-year basis, and net profit grew by 193% to INR33.9 crores. EBITDA grew by 40% to INR73 crores. EBITDA margin on a Page 3 of 11 Meghmani Organics Limited November 05, 2026 consolidated basis stood at 11% compared to 9% in the corresponding quarter of the previous year. For the half year ended 30th September 2026, our consolidated revenue stood at INR1,209 crores, up by 2%. Net profit increased by 239% on a year-on-year basis to INR82.1 crores, and EBITDA grew by 44% to INR171 crores. EBITDA margin on a consolidated basis stood at 14.1% compared to 10% in the corresponding previous year. As of 30th September 2026, on a standalone basis, our total debt stands at INR497 crores, comprising INR435 crores in the short-term debt and INR62 crores in the long-term debt. Debt-to-equity ratio on a stand-alone basis stood at 0.27x. On a consolidated basis, our total debt stands at INR661 crores, which includes INR438 crores in short-term debt and INR223 crores in the long-term debt. The debt-to-equity ratio on a consolidated basis stood at 0.41x. Till 30th September, we have made a debt repayment of approximately INR64 crores. So, to conclude, while the near-term environment remains challenging, [Showing first 8,000 characters — download PDF for full document]